DrugPatentWatch Database Preview
OXYCONTIN Drug Patent Profile
Email this page to a colleague
Which patents cover Oxycontin, and when can generic versions of Oxycontin launch?
Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are nineteen patents protecting this drug.
This drug has five hundred and sixty-four patent family members in forty-eight countries.
The generic ingredient in OXYCONTIN is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxycontin
A generic version of OXYCONTIN was approved as oxycodone hydrochloride by SPECGX LLC on June 30th, 2004.
Summary for OXYCONTIN
| International Patents: | 564 |
| US Patents: | 19 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Clinical Trials: | 59 |
| Patent Applications: | 4,237 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for OXYCONTIN |
| Drug Sales Revenues: | Drug sales revenues for OXYCONTIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXYCONTIN |
| What excipients (inactive ingredients) are in OXYCONTIN? | OXYCONTIN excipients list |
| DailyMed Link: | OXYCONTIN at DailyMed |
Recent Clinical Trials for OXYCONTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 2 |
| Khashayar Vaziri | Phase 2 |
| Karolinska Institutet | Phase 3 |
Pharmacology for OXYCONTIN
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for OXYCONTIN
US Patents and Regulatory Information for OXYCONTIN
OXYCONTIN is protected by nineteen US patents.
Patents protecting OXYCONTIN
Abuse-proofed dosage form
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Abuse-proofed dosage form
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Process for preparing oxycodone compositions
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Crush resistant delayed-release dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Abuse-proofed dosage form
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE
Oxycodone compositions
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Abuse-proofed dosage form
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Tamper resistant dosage forms
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-004 | Apr 5, 2010 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-003 | Apr 5, 2010 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXYCONTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-004 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-001 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-003 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OXYCONTIN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 363228 | ⤷ Try it Free |
| Denmark | 2305683 | ⤷ Try it Free |
| Russian Federation | 2010119291 | ⤷ Try it Free |
| South Korea | 101200700 | ⤷ Try it Free |
| Peru | 20050728 | ⤷ Try it Free |
| Russian Federation | 2004106611 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for OXYCONTIN
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Try it Free | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
